Table 4.
Subsequent Operation/Reoperation for 164 Patients Aged 6-16 Years With Type 2 TSFs (2000-2019) by Treatment Typea
| Treatment Group, No. (%)b | |||
|---|---|---|---|
| Reason for Procedure | Nonoperative (n = 41) | Operative (n = 123) | P Value |
| Any reasonc | 4 (9.8) | 26 (21) | .10 |
| Cartilage injury | 0 (0) | 1 (0.8) | .56 |
| Instrumentation removal | 0 (0) | 17 (14) | .01 |
| Lateral meniscal tear | 1 (2.4) | 0 (0) | .08 |
| Lysis of adhesions | 0 (0) | 7 (5.7) | .09 |
| Manipulation under anesthesia | 0 (0) | 7 (5.7) | .09 |
| New ACL partial tear | 1 (2.4) | 0 (0) | .08 |
| New TSF | 2 (4.9) | 0 (0) | .01 |
| Nonunion | 1 (2.4) | 1 (0.8) | .41 |
| Other | 1 (2.4) | 1 (0.8) | .41 |
aACL, anterior cruciate ligament; TSF, tibial spine fracture.
bData are presented as No. (%) of complications per treatment group unless otherwise indicated.
cExpressed as No. (%) of patients.